Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

L 627

Known as: L-627 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
ABSTRACT The pharmacokinetics and tolerability of a new parenteral carbapenem antibiotic, biapenem (L-627), were studied in… Expand
1995
1995
Biapenem, formerly LJC 10,627 or L-627, a carbapenem antibiotic, was studied in its interactions with 12 beta-lactamases… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
1994
1994
We tested 441 clinical strains of anaerobes by using a broth microdilution method to determine the in vitro activity of biapenem… Expand
  • table 1
1994
1994
Pharmacokinetic and clinical studies on biapenem (L-627), a newly developed carbapenem, were performed and the following results… Expand
1994
1994
Pharmacokinetic, bacteriological and clinical studies on biapenem (L-627), a newly developed carbapenem antibiotic, were… Expand
1993
1993
The in vitro activity of biapenem (formerly L-627 or LJC10, 627), a new carbapenem, was compared with that of imipenem and… Expand
1993
1993
The safety and pharmacokinetics of L-627, a new injectable carbapenem antibiotic, were evaluated in healthy volunteers. In single… Expand
1993
1993
The in vitro activity of biapenem, a new carbapenem previously designated L-627, was compared with those of imipenem and several… Expand
  • table 1
  • table 2
1992
1992
The in vitro activity of L-627, a new parenterally administered carbapenem, was compared with those of imipenem, meropenem, FCE… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
1992
1992
MICs of two new carbapenems, meropenem and L-627, and imipenem were determined against 98 strains of the Nocardia asteroides… Expand